Mouririelliptica: validation of gastroprotective, healing and anti-Helicobacter pylori effects

J Ethnopharmacol. 2009 Jun 25;123(3):359-68. doi: 10.1016/j.jep.2009.03.040. Epub 2009 Apr 5.

Abstract

Ethnopharmacological relevance: Mouriri elliptica Martius (Melastomataceae) is species reputed in folk medicine to heal gastric ulcer and gastritis.

Aim of the study: Methanolic extract (ME) and ethyl acetate fraction (EAF) from leaves of Mouriri elliptica were evaluated for their gastroprotective, healing, immunological, toxicological and anti-Helicobacter pylori activities.

Material and methods: The gastroprotective action of ME and EAF was evaluated in rodent experimental models and to elucidate mechanisms of action, the antisecretory action, involvements of NO, SH, PGE(2), anti-Helicobacter pylori action of ME was evaluated. We also used immunohistochemical (PCNA and COX-2) and immunomodulatory (murine peritoneal macrophages) assays to evaluate Mouriri elliptica effects.

Results: ME present gastroprotective action without antisecretory effect. Otherwise, ME showed anti-Helicobacter pylori action (MIC=0.025mug/mL) and was able to inhibit NO production by macrophages. This species also accelerate the healing of ulcerated gastric mucosa by stimulating proliferation factors (PCNA), COX-2 and maintained basal PGE(2) level independent action of NSAID in gastric mucosa. The phytochemical investigation showed that this species possesses phenolic acid derivatives, acylglycoflavonoids and condensed tannins which probably influenced their pharmacological action.

Conclusion: All these results suggest the efficacy and safety of Mouriri elliptica in combating and healing gastric ulcer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Animals
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anti-Ulcer Agents / adverse effects
  • Anti-Ulcer Agents / pharmacology
  • Anti-Ulcer Agents / therapeutic use*
  • Cyclooxygenase 2 / metabolism
  • Dinoprostone / metabolism
  • Disease Models, Animal
  • Ethanol
  • Female
  • Flavonoids / adverse effects
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Gastric Mucosa / drug effects*
  • Gastric Mucosa / metabolism
  • Helicobacter Infections / chemically induced
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects*
  • Macrophages / drug effects
  • Male
  • Melastomataceae* / chemistry
  • Mice
  • Nitric Oxide / antagonists & inhibitors
  • Phenols / adverse effects
  • Phenols / pharmacology
  • Phenols / therapeutic use
  • Phytotherapy*
  • Plant Extracts / adverse effects
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Plant Leaves
  • Proliferating Cell Nuclear Antigen / metabolism
  • Rats
  • Stomach Ulcer / chemically induced
  • Stomach Ulcer / drug therapy*
  • Stomach Ulcer / microbiology
  • Tannins / adverse effects
  • Tannins / pharmacology
  • Tannins / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anti-Ulcer Agents
  • Flavonoids
  • Phenols
  • Plant Extracts
  • Proliferating Cell Nuclear Antigen
  • Tannins
  • Nitric Oxide
  • Ethanol
  • Cyclooxygenase 2
  • Dinoprostone